The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Jalota Deepika since 2021.
This trader's CIK number is 1825192.
At the time of last reporting, Jalota Deepika was the Chief Development Officer of Pmv Pharmaceuticals, Inc.. (stock ticker symbol PMVP).
Also see all insider trading activities at Pmv Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PMVP | 0 | $0 | 33,065 | $35,214 | 0 | $0 |
| 2024 | PMVP | 0 | $0 | 7,218 | $10,855 | 0 | $0 |
| 2023 | PMVP | 0 | $0 | 4,104 | $27,168 | 0 | $0 |
| 2021 | PMVP | 0 | $0 | 2,896 | $97,815 | 2,896 | $10,222 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-01 | PMVP | Sale | 33,065 | 1.06 | 35,214 |
| 2024-09-11 | PMVP | Sale | 7,218 | 1.50 | 10,855 |
| 2023-09-15 | PMVP | Sale | 4,104 | 6.62 | 27,168 |
| 2021-08-17 | PMVP | Sale | 2,896 | 33.78 | 97,815 |
| 2021-08-17 | PMVP | Option Ex | 2,896 | 3.53 | 10,222 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jalota Deepika (Chief Development Officer of Pmv Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.